The popularity of drugs like Ozempic and Mounjaro could grow exponentially in the next few years, both for weight loss and a growing list of potential uses that are being studied. GLP-1 agonists, a class of medication typically used to treat Type 2 diabetes and obesity, have been available since 2005, but only in the...
Uncertainty over certification affects possible 9/11-related illnesses coverage
- today, 5:09 AM
- abcnews.go.com
- 0
No comments